West African Crystalline Maculopathy is an eye condition where tiny, shiny, yellow-green crystals collect in the very center of the retina (the fovea, the part that gives you sharp, central vision). It tends to show up in adults originally from West Africa. Many people have no symptoms at all, and vision is often normal. On a retina exam, the doctor sees small, refractile (light-reflecting) deposits clustered at the fovea; on OCT scans, these crystals sit in the most inner layers of the retina. The cause is not fully understood. Early case series suggested a link with certain West African foods (for example kola nut, cassava, palm oil), but later studies found inconsistent diets among patients and instead noticed a frequent association with other retinal vascular diseases like diabetic or sickle cell retinopathy. Overall, WACM generally behaves benignly—crystals can stay stable for years, sometimes increase, sometimes slowly fade—and it usually does not harm vision. JAMA NetworkPubMed+1PMCophthalmologyretina.org

West African crystalline maculopathy (WACM) is an eye condition in which tiny, shiny, yellow-green crystal-like specks appear in the macula (the central part of the retina that gives you sharp, reading vision). These specks look highly reflective when the retina is examined. They can occur in one eye or both eyes, and sometimes they are more obvious in one eye than the other. Importantly, many people with WACM do not notice any vision problem—the condition can be asymptomatic and discovered incidentally during a routine eye exam. The condition was first described in elderly Nigerians of the Igbo tribe in 2003 and has since been reported in other West Africans and people of West African origin. Although the crystals are easy to see on photographs and scans, WACM usually has a good prognosis and does not, by itself, cause visual loss. The crystals can even change over time—evolving, decreasing, or occasionally disappearing. JAMA NetworkEyeWiki

Researchers still do not know the precise substance that forms these crystals or the single exact cause. Several associations have been noticed, especially with retinal vascular diseases (like diabetic retinopathy or sickle cell retinopathy), which can weaken the blood–retinal barrier and may allow certain materials to seep into the retina and crystallize. Dietary factors were proposed early on, but later studies showed inconsistent links, so diet is considered a possible contributor—not a proven cause. AAO JournalPMCPubMed

---

Types

Because there is no universal official subtype system, clinicians often describe WACM using practical patterns that help with diagnosis and follow-up:

1. By laterality

• Unilateral WACM: crystals in one eye only.

• Bilateral, asymmetric WACM: crystals in both eyes but more in one eye; asymmetry is common. EyeWiki

2. By location in the retina

• Foveal-only pattern: crystals clustered at the very center (fovea).

• Foveal plus parafoveal pattern: crystals extend slightly around the fovea.

• Rare wider pattern: crystals also observed outside the center in some reports. JAMA Network

3. By associated retinal disease

• WACM with diabetic retinopathy: crystals plus signs of diabetes-related retinal damage (very commonly reported).

• WACM with sickle cell retinopathy: crystals occur alongside sickle-related retinal changes.

• WACM with other vascular disorders: e.g., branch retinal vein occlusion; or with conditions that disturb the blood–retinal barrier. AAO JournalPMC+1

4. By time course

• Stable WACM: crystals remain but vision stays good.

• Fluctuating WACM: crystals increase, shift, or reduce over months to years.

• Regressing WACM: crystals become fewer or vanish on later visits. EyeWiki

5. By depth on imaging

• Superficial/ILM layer crystals: at or near the internal limiting membrane (ILM).

• Henle fiber layer crystals: within the outer plexiform region at the macula.
  Multimodal imaging studies show crystals most often at these two levels. American Academy of Ophthalmology

---

Causes

Important note: No single proven cause has been confirmed. The items below reflect observed associations or hypotheses discussed in the literature.

1. West African ancestry
   Most reported cases involve people born in West Africa, notably Nigerians; this suggests a genetic or environmental background connected to the region. JAMA NetworkPubMed

2. Older age
   First reports were in late middle age to elderly adults (often 50s–70s); aging may alter retinal metabolism or barriers, making crystal deposition more likely. JAMA Network

3. Diabetic retinopathy
   Very commonly co-present; breakdown of the blood–retinal barrier (BRB) in diabetes may allow substances to leak and crystallize. AAO Journal+1

4. Sickle cell retinopathy
   Sickle-related vascular changes can disturb the BRB, again offering a pathway for crystal formation. PMC

5. Other retinal vascular diseases
   Examples include branch retinal vein occlusion and familial exudative vitreoretinopathy; all may impair retinal circulation or barrier function. PMC

6. Chronic macular edema (any cause)
   Fluid in the macula signifies BRB leakage; chronic leakage may carry molecules that later precipitate as crystals. (Mechanism inferred from reports of WACM with macular edema.) Ophthalmology Retina

7. Prior panretinal photocoagulation (PRP) in diabetes
   Some case series noted crystals in eyes with prior laser; PRP modifies retinal metabolism and vasculature, potentially affecting crystal dynamics. American Academy of OphthalmologyScienceDirect

8. Dietary factors (early hypothesis)
   Early reports proposed kola nut, cassava, and palm oil exposure; later work showed inconsistent dietary histories, so diet remains possible but unproven. AAO JournalPMC

9. Regional environmental exposures
   Living environments may include plant compounds or oils uncommon elsewhere; evidence is indirect and not definitive. (Inferred from geographic clustering.) PubMed

10. Genetic predisposition
    Because cases cluster in a specific population, a genetic component is possible, though family members often test negative, so this remains unconfirmed. PMC

11. Systemic hypertension
    Vascular stress can augment retinal leakage; occasionally reported alongside WACM as a co-morbidity rather than a proven driver. (Association via vascular retinopathy framework.) PubMed

12. Dyslipidemia
    Abnormal blood lipids can contribute to retinal exudates; some WACM cases also have lipid disturbances, but no causal proof exists. (Vascular risk context.) PubMed

13. Chronic inflammation/uveitis
    Cases noted with chronic cystoid macular edema from uveitis; inflammation compromises the BRB. Ophthalmology Retina

14. Ischemia-reperfusion in retina
    Any process that repeatedly starves and re-perfuses the macula can damage barriers, theoretically promoting deposition. (Mechanistic inference supported by vascular associations.) PMC

15. Oxidative stress in retinal tissue
    Oxidative by-products might aggregate or bind to lipids/proteins; this is a biological hypothesis rather than proven fact for WACM. (Supported as a general mechanism in crystalline maculopathies reviews.) PMC

16. Microstructural “trapping” at specific layers
    Crystals localize near the ILM and Henle fiber layer on imaging—layers where materials might accumulate mechanically. American Academy of Ophthalmology

17. Altered Müller cell function
    Müller glia manage retinal fluid and ions; dysfunction could favor local precipitation. (Plausible pathobiology; not yet proven specifically for WACM.) Ophthalmology Retina

18. Nutritional supplements or carotenoids (differential thought, not a WACM cause)
    Some drugs/supplements (e.g., canthaxanthin) cause other crystalline maculopathies; clinicians consider these in the differential to exclude them, not as WACM causes. PMC

19. Medications/toxins (differential to exclude)
    Tamoxifen and talc can cause crystalline deposits, but their pattern differs; excluding them helps confirm WACM. PMC

20. Idiopathic cases
    Even after thorough evaluation, many people have no identifiable trigger beyond the demographic pattern—underscoring that true causation remains unclear. PubMed

---

Symptoms

1. Often no symptoms at all
   Many people see normally; WACM is found during routine eye checks. EyeWiki

2. Mild blurring (if present)
   If vision is affected, it is usually because of an associated disease like diabetic macular edema—not the crystals themselves. AAO Journal

3. Distortion of straight lines (metamorphopsia)
   Possible if the macula is swollen from another cause.

4. Difficulty reading fine print
   Again, usually from coexisting macular changes, not the crystals per se.

5. Central gray spot (central scotoma)
   Uncommon in isolated WACM; more likely with macular edema.

6. Glare or light sensitivity
   Occasionally reported, nonspecific.

7. Reduced contrast sensitivity
   Fine detail may be harder to pick up in some cases with macular changes.

8. Color vision subtle changes
   If macular structure is altered by co-pathology.

9. Fluctuating vision
   May reflect changes in macular edema rather than crystals.

10. Eye strain with near work
    Non-specific, often from uncorrected refractive error.

11. Floaters
    From other retinal conditions (e.g., diabetic changes), not the crystals.

12. Night vision difficulty
    Usually unrelated to WACM directly; may reflect diabetic retinopathy.

13. Peripheral shadowing
    Not typical of WACM; could indicate another problem (e.g., vitreous hemorrhage or detachment)—important so clinicians do not miss other disease.

14. Mild ache or discomfort
    Rare; WACM is not an inflammatory pain condition.

15. Anxiety after seeing retinal photos
    Understanding that the crystals are often benign helps reassurance. EyeWiki

---

Diagnostic tests

Below are the key tests used to identify WACM, exclude look-alike conditions, and check for associated diseases. I’ve grouped them as requested.

A) Physical exam (clinic-based observation)

1. Detailed history and risk review
   Ask about West African birthplace, age, diabetes, sickle cell disease/trait, prior eye lasers, diet, and medications/supplements (to rule out non-WACM crystalline maculopathies such as tamoxifen or canthaxanthin). This steers diagnosis and differential. PMC

2. Best-corrected visual acuity (BCVA)
   Measures central vision; in isolated WACM, acuity is often normal. EyeWiki

3. Amsler grid
   Simple grid to detect central distortion—useful if macular edema is suspected.

4. Color vision testing
   Can reveal subtle macular dysfunction from associated disease.

5. Contrast sensitivity
   Picks up fine vision changes missed by standard charts.

6. Dilated slit-lamp biomicroscopy of the macula
   Using high-power lenses, the clinician can see the tiny, highly reflective yellow-green crystals clustered at the fovea—the hallmark of WACM. JAMA Network

B) Manual tests (hands-on clinical maneuvers/instruments)

7. Indirect ophthalmoscopy
   Gives a wide-field view for additional crystals or coexisting vascular changes elsewhere. AAO Journal

8. Applanation tonometry
   Checks eye pressure; important when uveitic edema or diabetic neovascular changes are present (co-pathologies).

9. Confrontation visual fields
   Screens for central or paracentral defects that might reflect macular disease.

10. Refraction/pinhole test
    Ensures any blurring is not just from uncorrected glasses power.

C) Lab & pathological tests (to evaluate associations and exclude look-alikes)

11. Fasting glucose and HbA1c
    Identify or stage diabetes, a frequent co-condition with WACM. AAO Journal

12. Hemoglobin electrophoresis
    Checks for sickle cell disease or trait, linked in reports of WACM with sickle cell retinopathy. PMC

13. Lipid profile
    Evaluates dyslipidemia that may worsen vascular leakage; supportive rather than diagnostic.

14. Medication/supplement review ± targeted testing
    When uncertain, clinicians specifically exclude other crystalline maculopathies (e.g., tamoxifen, canthaxanthin exposure, or talc). PMC

D) Electrodiagnostic tests (functional retinal testing)

15. Full-field electroretinography (ERG)
    Usually normal in localized macular disease like WACM; helps rule out generalized retinal dysfunction.

16. Multifocal ERG (mfERG)
    Assesses macular function region-by-region; may be slightly reduced if there is macular edema or co-pathology.

17. Electro-oculography (EOG)
    Typically normal; included when diagnostic doubt remains.

E) Imaging tests (the most informative for WACM)

18. Color fundus photography
    Documents the sparkling, yellow-green crystals at the fovea and tracks them over time. JAMA Network

19. Spectral-domain optical coherence tomography (OCT)
    Cross-sectional “microscopic” retinal scan; in WACM it can localize crystals mainly at the ILM and/or Henle fiber layer; also shows whether there is macular edema. American Academy of Ophthalmology

20. Fundus autofluorescence (FAF)
    Highlights lipofuscin patterns; crystals may show distinctive reflectance, and FAF helps exclude other macular deposits.

Non-pharmacological treatments (therapies & practical measures)

Note: These do not remove crystals. They focus on safe eye care, monitoring, and control of associated conditions that commonly accompany WACM.

1. Education & reassurance — Explain that WACM is usually benign and vision-sparing. Reduces anxiety and improves follow-up. EyeWiki

2. Regular retina follow-up — Periodic exams (e.g., yearly or as advised) to photograph the macula and track any changes. Helps distinguish WACM from other crystalline retinopathies. PubMed

3. OCT monitoring — Noninvasive scan shows crystal location and any retinal swelling; useful to confirm the diagnosis and watch stability. PubMed

4. Color fundus photography — Baseline and serial photos document crystal pattern and density over time. EyeWiki

5. Fundus autofluorescence (FAF) — May help rule in/out alternative crystalline disorders; WACM typically shows a characteristic macular pattern without widespread RPE disease. (General imaging principle.) PMC

6. Control of diabetes (if present) — Tight glucose, blood pressure, and lipid control reduces risk of diabetic retinopathy progression, which is frequently co-present with WACM. Scholars@Duke

7. Sickle cell care (if present) — Specialist hematology/retina care lowers complications from sickle cell retinopathy, which has been reported with WACM. PMC

8. Lifestyle cardiovascular risk reduction — Healthy diet, activity, smoking cessation support retinal vascular health overall. (General vascular-retina principle supported across retinopathies.) PubMed

9. Medication review — Ensure no confusing look-alikes (e.g., tamoxifen, canthaxanthin) that cause other crystalline maculopathies; if present, discuss with the prescribing doctor. (Differential diagnosis principle.) PubMed

10. Avoid unproven “eye crystal cleansers” — No evidence that topical drops, rinses, or at-home remedies remove WACM crystals. (Evidence gap; safety principle.) EyeWiki

11. Sun/UV protection — Sensible use of sunglasses outdoors to reduce glare; comfort measure (not disease-modifying).

12. Nutrition for retinal health — Balanced diet rich in leafy greens and fish is sensible, but no diet has proven to clear WACM crystals. (Avoid strong claims.) PubMed

13. Home vision awareness — Amsler-type self-checks or simply noticing new distortion, blind spots, or sudden floaters can trigger earlier clinic review.

14. Photography/record keeping — Patients can keep copies of their imaging and reports; helpful if moving or changing providers.

15. Pregnancy planning (if applicable) — For coexisting sickle cell or diabetes, pre-pregnancy optimization reduces retinal risks. PMC

16. Occupational/visual ergonomics — Good lighting, contrast, and breaks reduce eye strain if minor glare or scintillation is noticed.

17. Comorbidity screening — Check for hypertension, hyperlipidemia—conditions linked to retinal vascular health. PubMed

18. Safe cultural dietary discussion — If a patient wishes to reduce kola-nut or similar intake, clinicians can discuss culturally sensitive, safe choices—while clarifying that the food–disease link is unproven and inconsistent. PMC

19. Psychological support if anxious — Rare diagnoses can cause worry; reassurance and, if needed, counseling improve quality of life.

20. Prompt evaluation of new symptoms — Sudden vision loss, new distortions, or flashes/floaters warrant urgent assessment to rule out non-WACM causes (e.g., retinal tear, vascular events).

Drug treatments

Key message: There is no proven medication that removes WACM crystals or changes the natural course. Drugs are used only if there is an associated retinal disease (for example, diabetic macular edema or proliferative diabetic retinopathy) or a systemic disease (diabetes, sickle cell). I’ll list common evidence-based drugs used for those comorbidities—not to treat WACM itself.

1. Intravitreal anti-VEGF (ranibizumab) — Class: anti-VEGF; Dosage/Timing: monthly loading then treat-and-extend per DME/PDR guidelines; Purpose: reduce edema/neovascularization; Mechanism: VEGF inhibition; Side effects: injection-related risks (endophthalmitis, IOP spike). For DME/PDR, not WACM itself.

2. Aflibercept — Similar use/purpose as above; sometimes offers greater anatomic response in DME in some trials; same injection risks.

3. Bevacizumab (off-label intraocular) — Cost-effective anti-VEGF alternative; same risks/benefits framework.

4. Intravitreal corticosteroid implant (dexamethasone) — Class: steroid; Dosing: implant lasting months; Purpose: reduce diabetic macular edema; Mechanism: anti-inflammatory/anti-permeability; Side effects: IOP rise, cataract.

5. Topical IOP-lowering drops — Class: various; only if steroid-induced IOP rise after injections/implants; not for WACM itself.

6. Systemic diabetes therapy (metformin) — Purpose: glycemic control; Mechanism: improves insulin sensitivity; Side effects: GI upset, rare lactic acidosis; Benefit: lowers diabetic retinopathy risk long-term.

7. Systemic insulin regimens — Purpose: glucose control; close monitoring reduces retinopathy progression risk.

8. Statins — Purpose: lipid control; Mechanism: HMG-CoA reductase inhibition; Side effects: myalgia, transaminitis; Rationale: cardiovascular risk reduction in patients with comorbid dyslipidemia.

9. Antihypertensives (ACE inhibitors/ARBs) — Purpose: BP control to protect microvasculature; Side effects depend on class (e.g., cough with ACE-i).

10. Hydroxyurea (sickle cell disease, hematology-guided) — Purpose: reduce vaso-occlusive episodes and hemolysis; Mechanism: increases HbF; Side effects: cytopenias; Rationale: systemic control may reduce retinal complications of sickle cell disease. Specialist-supervised. PMC

Why not “crystal-dissolving” drops or pills?
Because no clinical study shows a medication removes WACM crystals or improves vision specifically for WACM. Management focuses on associated diseases and observation. EyeWiki

---

Dietary molecular supplements

There are no supplements proven to clear WACM crystals. If a patient wishes to support general retinal health, these are commonly discussed nutrients; they should be considered adjuncts, not treatments, and reviewed with a clinician—especially if pregnant, on blood thinners, or with chronic illness.

1. Lutein/Zeaxanthin — Carotenoids concentrated in the macula; potential antioxidant support.

2. Omega-3 fatty acids (DHA/EPA) — Support neuronal membranes; general cardiovascular benefit.

3. Vitamin C — Water-soluble antioxidant; avoid megadoses.

4. Vitamin E — Lipid-phase antioxidant; avoid high doses in anticoagulated patients.

5. Zinc — Cofactor in retinal enzymes; excess can cause GI upset/copper deficiency.

6. Copper — Balanced with zinc to avoid deficiency.

7. Vitamin B-complex (B6, B12, folate) — Supports general neurovascular health; avoid self-treating B12 deficiency without testing.

8. Resveratrol (grape-derived) — Antioxidant role is theoretical in retina; evidence is not specific to WACM.

9. Astaxanthin — Carotenoid with antioxidant properties; evidence in retinal disease is limited.

10. Coenzyme Q10 — Mitochondrial cofactor; limited ocular evidence.

Typical dosing: Use commercially available, moderate-dose formulas (e.g., “eye health” blends), unless a clinician recommends a specific regimen. Again, these do not treat WACM, and data are extrapolated from general retinal health research rather than WACM trials.

---

Regenerative / stem cell drugs

Important safety note: There are no approved “immunity booster,” regenerative, or stem-cell drugs for WACM. Offering or using such products for this condition would be speculative and potentially unsafe. What you can do safely:

1. Vaccination & infection prevention per national guidelines — Supports overall health; no WACM-specific effect.

2. Optimize sleep, nutrition, exercise — General immune support; no crystal impact.

3. Treat systemic inflammation appropriately — Under medical supervision only.

4. Avoid unregulated stem-cell injections — Significant risk of infection, inflammation, and vision loss; not approved for WACM.

5. Participate in clinical trials only if available and ethical — None are standard for WACM at present.

6. Second opinions at retina centers — To confirm diagnosis and avoid unsafe experimental therapies.

This section is a refusal to recommend unproven or risky therapies, for your safety and in line with current evidence. PubMed

---

Surgeries (what’s actually done—and when)

There is no surgery to remove WACM crystals. However, if a coexisting retinal disease needs treatment, standard procedures may be used:

1. Panretinal photocoagulation (PRP) laser — For proliferative diabetic or sickle cell retinopathy to shrink abnormal vessels and prevent bleeding. In some reports, treating the underlying retinopathy changed the crystal pattern, but this is not a “crystal treatment.” Scholars@Duke

2. Focal/grid macular laser — Occasionally used for focal diabetic edema (less common now vs. anti-VEGF).

3. Pars plana vitrectomy — For complications such as non-clearing vitreous hemorrhage or tractional retinal detachment in advanced proliferative retinopathy.

4. Laser for peripheral ischemia in sickle cell retinopathy — Targets “sea-fan” neovascularization to reduce bleeding risk. PMC

5. Cataract surgery — Not for WACM, but may be needed if age-related cataract impairs vision; crystals typically still remain but are incidental.

---

Preventions

Because the cause of WACM is unknown, we cannot promise prevention. The goal is to protect overall retinal health and lower risk from associated conditions.

1. Routine eye exams (especially if West African origin or with diabetic/sickle history). PubMed

2. Good diabetes control to lower retinopathy risk.

3. Blood pressure and lipid control to protect retinal vessels.

4. No smoking to improve microvascular health.

5. Prompt care for sickle cell complications and regular hematology follow-up. PMC

6. Balanced diet and weight control for cardiometabolic health.

7. Medication awareness — avoid confusing look-alikes when possible (only with prescriber’s guidance). PubMed

8. Eye protection & sun sense to reduce glare and strain.

9. Know your baseline — keep copies of images for comparison.

10. Avoid unproven therapies marketed for “crystal removal.”

---

When to see a doctor

• You notice new blurring, distortion, or a dark spot in central vision.

• You develop sudden floaters, flashes, or a curtain over vision.

• You have diabetes or sickle cell disease and it’s been over a year since your last retina check. PMC

• You are unsure whether a new medicine or supplement could affect your eyes.

• You want a second opinion to confirm WACM and rule out other crystalline maculopathies (e.g., tamoxifen toxicity, Bietti). PubMed

---

What to eat” and “what to avoid”

There is no proven WACM diet. Early reports mentioned kola nut/cassava/palm oil, but later studies found inconsistent dietary histories, so we should not claim a cause-and-effect. If you personally prefer to limit those foods, do it safely and culturally appropriately—but it’s optional. PMC

What to eat (general retinal & vascular health):

1. Leafy greens (spinach, kale)—lutein/zeaxanthin;

2. Colorful vegetables and fruits—antioxidants;

3. Oily fish (e.g., sardine, mackerel)—omega-3s;

4. Whole grains and legumes;

5. Nuts in moderation (unless you choose to limit kola nut for personal reasons);
   What to avoid/limit:

6. Tobacco;

7. Excess sugar/refined carbs (for diabetes risk);

8. Excess salt (for BP);

9. Trans fats;

10. High-dose, unregulated supplements or “miracle” eye products.

---

Frequently Asked Questions (FAQ)

1) Does WACM cause blindness?
Very unlikely. Most patients maintain good vision; the crystals are often an incidental finding. EyeWiki

2) Can eye drops or pills dissolve the crystals?
No therapy has been shown to remove WACM crystals. Doctors observe and treat any associated retinopathy if present. EyeWiki

3) Is this the same as Bietti crystalline dystrophy or tamoxifen retinopathy?
No. Those have different patterns, causes, and often different symptoms. Your doctor rules them out by history and imaging. PubMed

4) Why is it called “West African”?
It was first described in older adults from the Igbo tribe in Nigeria and remains reported almost exclusively in people born in Africa. JAMA NetworkPubMed

5) Did kola nut or cassava cause my crystals?
A definite link has not been proven. Later studies found many patients did not consume those foods consistently. PMC

6) Will the crystals spread?
They may stay stable, increase a little, or even slowly fade over years; vision often stays good. EyeWiki

7) What tests will I get?
Dilated eye exam, fundus photographs, and OCT scans. Sometimes autofluorescence or other imaging to rule out mimics. PubMed

8) Can lasers remove the crystals?
No. Lasers can treat coexisting diabetic or sickle cell retinopathy; in some reports, treating those conditions changed crystal patterns, but laser is not a crystal-removal tool. Scholars@Duke

9) Should my family be screened?
There’s no proven inheritance pattern. Routine eye care is sensible, especially if they have diabetes or sickle cell disease. PubMed

10) Could this be from a medicine I take?
WACM itself isn’t linked to a specific drug. Your doctor will still review medications that can cause other crystalline maculopathies. PubMed

11) Is WACM common?
No, it’s rare—even in regions where it was first recognized. JAMA Network

12) Will glasses help?
Glasses won’t change crystals but can optimize vision if you have refractive error or age-related presbyopia.

13) Can I fly or exercise?
Yes, unless your doctor tells you otherwise for another eye condition. WACM itself doesn’t restrict routine activities.

14) Are supplements worth it?
No supplement is proven to treat WACM. If you choose general eye-health supplements, use moderate doses and review with your clinician.

15) What should I watch for at home?
Any new blurring, distortion, floaters, flashes, or a curtain in vision—get urgent care to rule out other retinal problems.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 30, 2025.